BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16886653)

  • 21. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
    Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
    Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery.
    Flannery TW; Suntharalingam M; Regine WF; Chin LS; Krasna MJ; Shehata MK; Edelman MJ; Kremer M; Patchell RA; Kwok Y
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):19-23. PubMed ID: 18280058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC
    Cancer; 2007 Jan; 109(2):274-81. PubMed ID: 17154161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
    Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Bamias A; Pavlidis N; Kalofonos HP; Timotheadou E; Samantas E; Briasoulis E; Skarlos DV; Economopoulos T; Dimopoulos MA;
    Anticancer Res; 2009 Feb; 29(2):745-51. PubMed ID: 19331231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.
    Kim HJ; Kim YJ; Seo MD; Yi HG; Lee SH; Lee SM; Kim DW; Yang SC; Lee CT; Lee JS; Kim YW; Heo DS
    Lung Cancer; 2009 Aug; 65(2):242-6. PubMed ID: 19147252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study.
    Kim JH; Kim HS; Kwon JH; Park S; Kim HY; Jung JY; Kim HJ; Song HH; Lee GW; Lee SI; Gong SJ; Lee JA; Kim KJ; Zang DY
    Lung Cancer; 2009 Mar; 63(3):405-9. PubMed ID: 18621432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival in untreated early stage non-small cell lung cancer.
    Chadha AS; Ganti AK; Sohi JS; Sahmoun AE; Mehdi SA
    Anticancer Res; 2005; 25(5):3517-20. PubMed ID: 16101172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical manifestation and survival of patients with non-small cell lung cancer.
    Thammakumpee K
    J Med Assoc Thai; 2004 May; 87(5):503-7. PubMed ID: 15222519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
    Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
    J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden.
    Berglund A; Holmberg L; Tishelman C; Wagenius G; Eaker S; Lambe M
    Thorax; 2010 Apr; 65(4):327-33. PubMed ID: 20388758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
    Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five years managing metastatic non-small cell lung cancer: experience at a teaching hospital.
    Wong S; Rosenthal MA; deBoer R; Green MD; Fox RM
    Intern Med J; 2004 Aug; 34(8):458-63. PubMed ID: 15317543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.